Updated Jul 16, 2026
Sattarzadeh Sherwin is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Sattarzadeh Sherwin is listed in the SEC filing context as affiliated with Galecto, Inc. as of 2026-01-27. Galecto, Inc. is a biotechnology company involved in developing novel therapeutics (the public SEC filings describe an insider/affiliated relationship with the company). The available public record provided for this context does not reveal a widely published biography, education, or detailed professional history. Therefore, the profile remains limited to the connection to Galecto, Inc. with no confirmed title or role disclosed in the provided SEC documentation.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-27 | DMRA | Damora Therapeutics, Inc. | A — Grant or award | 190.4K | $0.00 |
Sattarzadeh Sherwin is listed in the SEC filing context as affiliated with Galecto, Inc. as of 2026-01-27. Galecto, Inc. is a biotechnology company involved in developing novel therapeutics (the public SEC filings describe an insider/affiliated relationship with the company). The available public record provided for this context does not reveal a widely published biography, edu…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sattarzadeh Sherwin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.